文献速递传染病防控与疫情报告免疫规划

2008至2015年中国EV-A71疫苗引入前手足口病流行病学

Epidemiology of hand, foot and mouth disease in China, 2008 to 2015 prior to the introduction of EV-A71 vaccine.
PubMed 文献 · Euro Surveill · 2017-01-01

该研究基于国家监测系统2008至2015年手足口病报告数据,描述EV-A71疫苗引入前中国手足口病流行病学特征。EV-A71是致死(88.5%-95.4%)和重症(50.7%-82.3%)病例的主要血清型,各血清型相关发病率与重症风险在1岁及以下儿童最高并随年龄增长下降。研究为评估疫苗影响和潜在血清型替换提供基线流行病学。

要点

  • EV-A71是2008至2015年中国手足口病致死和重症病例的主要血清型。
  • 各血清型手足口病发病率和重症风险在1岁及以下儿童最高,随年龄增长下降。
  • 2013和2015年轻症病例中其他肠道病毒更常见(48.8%和52.5%)。

核心结论

  • 本研究为评估EV-A71疫苗影响和潜在血清型替换提供了基线流行病学数据。

研究设计与样本

  • 利用国家监测系统的报告数据,描述2008至2015年EV-A71疫苗接种引入前中国手足口病的流行病学和动态。

主要发现

  • 实验室鉴定的血清型类别(CV-A16、EV-A71和其他肠道病毒)每年循环出现。
  • EV-A71保持最强毒力,是各年度致死病例(范围88.5%-95.4%)和重症病例(范围50.7%-82.3%)的主要血清型。
  • 除2013和2015年其他肠道病毒在轻症手足口病中更常见(48.8%和52.5%)外,研究覆盖的其余年份EV-A71在轻症病例中更常检出(范围39.4%-52.6%)。
  • 所有血清型类别相关的手足口病发病率和重症风险均在1岁及以下儿童最高,并随年龄增长而下降。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Hand, foot and mouth disease (HFMD) is usually caused by several serotypes from human enterovirus A species, including enterovirus 71 (EV-A71) and coxsackievirus A16 (CV-A16). Two inactivated monovalent EV-A71 vaccines have been recently licensed in China and monovalent CV-A16 vaccine and bivalent EV-A71 and CV-A16 vaccine are under development. METHODS: Using notifications from the national surveillance system, we describe the epidemiology and dynamics of HFMD in the country, before the introduction of EV-A71 vaccination, from 2008 through 2015. RESULTS: Laboratory-identified serotype categories, i.e. CV-A16, EV-A71 and other enteroviruses, circulated annually. EV-A71 remained the most virulent serotype and was the major serotype for fatal cases (range: 88.5-95.4%) and severe cases (range: 50.7-82.3%) across years. Except for 2013 and 2015, when other enteroviruses were more frequently found in mild HFMD (48.8% and 52.5%), EV-A71 was more frequently detected from mild cases in the rest of the years covered by the study (range: 39.4-52.6%). The incidence rates and severity risks of HFMD associated with all serotype categories were the highest for children aged 1 year and younger, and decreased with increasing age. DISCUSSION/CONCLUSION: This study provides baseline epidemiology for evaluation of vaccine impact and potential serotype replacement.

来源:Euro Surveill,查看原文。版权归原作者所有。

引用

  1. Yang B, Liu F, Liao Q, et al. Epidemiology of hand, foot and mouth disease in China, 2008 to 2015 prior to the introduction of EV-A71 vaccine. Euro Surveill. 2017. PMID: 29258646. doi:10.2807/1560-7917.ES.2017.22.50.16-00824

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。